-
Fosun Pharma's new crown vaccine has been urgently used in Hong Kong
Time of Update: 2021-03-09
(Pharmaceutical Mingkangde) Tiantian Bio and MorphoSys announced that TJ2101 clinical studies completed the first patient dosing January 26, Tiantian Biology and German MorphoSys jointly announced that TJ210/MOR210 single-drug treatment recurrence or resusable advanced solid tumors of the United States Phase 1 dose climbing trial has completed the first patient.
-
Bai osaitu has a strategic cooperation agreement with Libero Thera of Japan
Time of Update: 2021-03-09
Libero Thera is responsible for antigen preparation and participation in in vitro antibody screening, and Baiosaitu will use its RenMab® mouse platform to conduct GPCR antibody discovery and complete the screening of lead antibody candidate molecules through drug ability evaluation techniques in animals.
-
Gifeitinib is "named" as a small molecule targeting drugs
Time of Update: 2021-03-09
Figure 2 Pharmaceutical segment composition in the field of anti-tumor drugs according to the PDB drug comprehensive database statistics (see Figure 3), in the small molecular targeting drug family, we found that imatinib, giffeitinib and ecstasy in 2016, cumulative sales reached 1,155 million yuan, accounting for 61.8% of the entire family at that time!
-
It's sunny! Take 5 more than $1 billion imitation 32 over-reviewed varieties bright...
Time of Update: 2021-03-09
Recently, Zhengda Qing pharmaceutical industry happy news: Androtini's fourth adaptive disease was approved, 5 varieties to choose the fourth batch of collection. meters of intranet data show that i
-
World Cancer Day: Professor Bai Chunmei: Real-world study of second-line treatment for advanced pancreatic cancer...
Time of Update: 2021-03-08
Pancreatic cancer, as one of the most mortal malignancies, is a veritable "king of cancer". of pure surgical techniques has not brought about a significant improvement in patient prognostication, and
-
Science Wins Total Cancer - The World's First CDK4/6 Inhibitor Continues to Sound...
Time of Update: 2021-03-08
Every year on February 4th, World Cancer Day is established by the International Alliance against Cancer (UICC) and the World Health Organization (WHO) to promote cancer prevention and treatment worldwide, to raise the level of early diagnosis of cancer and reduce the incidence of cancer, and this year's theme is "Caring for Patients and Fighting Cancer Together "I am and I will".
-
19.29 million new cancer cases in 2020 Cell technology is a new breakthrough...
Time of Update: 2021-03-08
CAR-T immunotherapy is a kind of genetic engineering technology to modify patients' T cells so that they can express chime antigens to specifically identify and kill cancer cells to play an anti-tumor role, is currently the focus of research in ACT treatment.
-
Heng Rui, a "Pharma Express" company, took the exclusive interest in PI3k inhibitors in China
Time of Update: 2021-03-08
(Sina Pharmaceutical News) Microcore Biology: Theo Ronnie capsule approved clinical trial February 9, microcore bio-announcement, the company recently received NMPA's new drug clinical trial application "acceptance notice", the product name is Theo Ronnie capsule.
-
Retail pharmacy chemical drug "iron triangle" easy to master! Vitamin and mineral supplements become "explosive...
Time of Update: 2021-03-08
Figure 2: Sample city retail pharmacy share trend from January 2019 to November 2020 Source: Minet retail drug monitoring system (10,000 retail physical pharmacies, including cities and counties) from the sample pharmacy monthly share trend, during the outbreak of the new crown epidemic, the share of medical devices in the first half of 2020 rose sharply, peaked in March, the second half of the market share stabilized, but the market share is significantly higher than in 2019.
-
Sangershi Risk Briefing Series: Antibiotic Drug Market Risk Analysis
Time of Update: 2021-03-08
2. Overcapacity In 2018, China's production of antibiotic raw materials is about 196,000 tons, taking penicillin industrial salt as an example, the current domestic production capacity has reached 100,000 tons / year, and the total annual global market demand is only 56,000 tons.
-
Diagnosed with advanced lung cancer You have these treatment options
Time of Update: 2021-03-08
past, several large-scale clinical studies have fully demonstrated that the first- and second-generation EGFR-TK inhibitors used in patients with EGFR-sensitive mutations can significantly improve objective remission rate (ORR) and quality of life compared to traditional chemotherapy, significantly prolonging patients' progression-free survival.
-
Take stock | more than 20 new Chinese drugs that will be eligible for FDA orphan drugs by 2020
Time of Update: 2021-03-08
6, Drugs: Xindili monoanti-anti-research and development enterprises: Cinda biotherapic diseases: T-cell lymphoma, esophageal cancer Xindili mono-antibody as a PD-1 monoclonal antibody, in December 2018 was approved by China's State Drug Administration (NMPA) to treat recurrence/refractic classic Hodgkin lymphoma.
-
Regenerative meta/Sanofi PD-1 inhibitors were given a second adaptive disorder
Time of Update: 2021-03-08
Today, Regeneron and Sanofi jointly announced that the FDA has approved the PD-1 inhibitor Libtayo (cemiplimab) extended adaptation to treat patients with advanced substrate cell carcinoma (BCC).
" FDA approval today of Libtayo will change the treatment model for patients with advanced substrate cell carcinoma.
-
Guojian-Sanno bioCAR-NK cell therapy is declared clinical in China
Time of Update: 2021-03-08
study published in the New England Journal of Medicine (NEJM) in 2020 found that 11 cancer patients received a CAR-NK therapy that targeted CD19 without the toxic effects common to CAR-T therapy.
-
Nature: Scientists reveal regulating immune cells
Time of Update: 2021-03-08
Subir Biswas, a researcher, said the results of this study show that the use of immunotherapy may enhance the coordinated response of the body's B-cell nuclear T-cells against ovarian cancer, which is also a immunogenic disease that is resistant to checkpoint inhibitors, which often show better disease treatment.
-
The retail market for 240 billion drugs is bucking the trend of price cuts
Time of Update: 2021-03-08
Sales of physical pharmacies, including urban and county) chemicals: anti-tumor and immunomodulants decreased significantly, cardiovascular system drugs counter-trend growth of national volume procurement of chemical drugs mainly, according to the Minenet retail drug monitoring data show that in 2020, the average unit price of end-of-life chemical drugs in china's urban physical pharmacies decreased by 2.01% YoY.
-
Tiantian Bio announced that TJ107 has completed the first patient drug treatment in Phase 2 clinical studies in China
Time of Update: 2021-03-08
On February 4, Tiantian Bio announced that its new long-acting recombinant human lebinocyte interlethional 7 (rhIL-7) TJ107 treatment of glioblastoma in China Phase 2 clinical trial has completed the first patient drug.
-
Reduce the side effects of cell therapy! Pfizer's research team uses this small molecule as a "switch"
Time of Update: 2021-03-08
team from Pfizer has designed a single-module CAR that can be activated under certain conditions, with tumor antigens that are directly regulated by FDA-approved small molecule drugs, ultimately regulating CAR-T cell activity.
-
New ideas for access to high-value innovative drug medical insurance under the multi-level guarantee framework
Time of Update: 2021-03-08
the extraterritory implementation of the key price agreement refers to the access of medical insurance, the medical insurance department and enterprises through the budget impact analysis (BIA) measurement results, to determine the high-value innovative drugs of the health insurance fund expenditure ceiling as a risk point.
-
12 new class 1 drug batch clinical, from Sanofi, Yingpai Pharmaceuticals and other companies | Cde...
Time of Update: 2021-03-08
May 2020, the drug has been approved clinically in the United States for the treatment of IDH1 mutations in solid tumors including advanced bile tube cancer, cartilage sarcoma and glioma.
